United States· US:63833-892_703efe5b-eb9f-4690-abb8-e446feaa702f

Riastap

A medicinal product containing fibrinogen human, registered in United States by CSL Behring GmbH.

US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fibrinogen humanAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: FIBRINOGEN HUMAN
Manufacturer: CSL Behring GmbH
Country: United States (US)
ATC code: —
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
63833-892-51
ndc11
6383389251
1 VIAL, GLASS in 1 CARTON (63833-892-51) / 100 mL in 1 VIAL, GLASS (63833-892-90)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fibrinogen human in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fibrinogen human products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Fibclot, Fibryga
Belgium · Fibclot, Fibryga
Bulgaria · Fibryga, Хемокомплетан P
Cyprus · Fibryga, Riastap
Czechia · Fibryga, Haemocomplettan P
Germany · Fibclot, Fibryga
Denmark · Fibclot, Fibryga
Estonia · Fibryga
Spain · Fibclot, Fibryga
Finland · Fibclot, Fibryga
France · Clottafact, Fibryga
United Kingdom (Northern Ireland) · Fibclot, Fibryga
Greece · Fibclot, Riastap
Croatia · Fibryga
Hungary · Fibclot, Fibryga
Ireland · Fibryga, Riastap
Iceland · Fibryga, Riastap
Italy · Fibriclotte, Fibryga
Lithuania · Fibryga
Luxembourg · Fibclot, Fibryga
Latvia · Fibryga
Malta · Fibryga, Riastap
Netherlands · Fibclot, Fibryga
Norway · Fibclot, Fibryga
Poland · Fibryga, Riastap
Portugal · Fibryga, Haemocomplettan
Romania · Fibryga, Haemocomplettan P
Sweden · Fibclot, Fibryga
Slovenia · Fibrema, Prufibry
Slovakia · Fibryga, Riastap

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/102eaf1d-970f-486b-a207-8b015596bc12
GET /v1/drugs/102eaf1d-970f-486b-a207-8b015596bc12?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "2600",
  "substance": "FIBRINOGEN HUMAN",
  "productndc": "63833-892",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/100mL",
  "application_number": "BLA125317",
  "marketing_category": "BLA"
}

API reference MCP server Plans

See everything about fibrinogen human.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console